1.
Salih SR, Majeed A, Hussein K, Yasin Y, Jumaa A. Dual Drug Repurposing in Cervical Cancer: The Synergistic Cytotoxic Effect of Dapagliflozin-Etoricoxib and Its Predicted Modulation of PI3K/Akt/mTOR Signaling via Molecular Docking. apjcb [Internet]. 26Oct.2025 [cited 29Oct.2025];10(4):821-35. Available from: http://waocp.com/journal/index.php/apjcb/article/view/1998